Feline Respiratory Infections: Etiology, Transmission, Clinical Management, and Zoonotic Potential

Introduction

Feline respiratory infections represent a complex of contagious diseases affecting the upper and lower respiratory tracts of domestic cats. These infections are typically polymicrobial, involving both viral and bacterial pathogens that act synergistically to produce clinical disease [1]. The most common etiologic agents include feline herpesvirus 1 (FHV-1), feline calicivirus (FCV), Chlamydia felis, Bordetella bronchiseptica, and Mycoplasma species [2]. Secondary bacterial infections frequently exacerbate primary viral damage, leading to more severe clinical outcomes [3]. Understanding the etiology, transmission dynamics, clinical management strategies, and zoonotic potential of these infections is essential for veterinary practitioners, diagnosticians, and public health professionals.

Etiology

Viral Agents

FHV-1 is an enveloped, double-stranded DNA virus belonging to the family Herpesviridae [1]. The virus exhibits tropism for mucosal epithelial cells of the upper respiratory tract and conjunctiva, causing cytolytic infection with characteristic syncytia formation [2]. Latency is established in trigeminal ganglia, and reactivation occurs during periods of stress or immunosuppression [3].

FCV is a non-enveloped, single-stranded RNA virus of the family Caliciviridae [1]. It displays high genetic diversity and mutability, resulting in multiple antigenic strains [2]. The virus replicates in oral and respiratory epithelial cells, causing vesiculation, ulceration, and rhinitis [3].

Bacterial Agents

Primary bacterial pathogens that cause feline respiratory disease include Chlamydia felis, Bordetella bronchiseptica, and Mycoplasma felis [2]. C. felis is an obligate intracellular Gram-negative bacterium with a biphasic life cycle alternating between infectious elementary bodies and metabolically active reticulate bodies [1]. B. bronchiseptica is a small, Gram-negative coccobacillus that expresses adhesins and toxins that impair mucociliary clearance [3]. M. felis lacks a cell wall and adheres to respiratory epithelial cells, disrupting ciliary function [2].

Secondary bacterial invaders frequently isolated from complicated cases include Pasteurella multocida, Streptococcus species, Staphylococcus species, and various enteric Gram-negative rods [1]. These organisms are often opportunistic pathogens that take advantage of virus-induced mucosal damage [3].

The following table summarizes key bacterial agents in feline respiratory infections.

How Do Cats Get Respiratory Infections

Transmission of feline respiratory pathogens occurs primarily through direct contact with infected cats or through exposure to fomites contaminated with respiratory secretions [1]. Aerosolized droplets produced during sneezing and coughing can travel short distances (up to 1–2 meters) and deposit on conjunctival or nasal mucosal surfaces [2]. FHV-1 is shed in ocular, nasal, and oral secretions, and transmission can also occur via contaminated litter boxes, food bowls, and bedding [3]. FCV is highly stable in the environment and can persist on dry surfaces for weeks, facilitating indirect transmission [1]. B. bronchiseptica is shed in respiratory exudates and can be transmitted through direct nose-to-nose contact or via contaminated water sources [2]. C. felis is shed in ocular and nasal discharges and requires close contact for transmission due to its intracellular nature [3].

Stress factors such as overcrowding, poor ventilation, concurrent disease, and recent transportation increase susceptibility to infection and promote shedding of latent FHV-1 [1]. Shelters, boarding facilities, and multi-cat households are high-risk environments for respiratory disease transmission [2].

Are Cat Respiratory Infections Dangerous

The clinical severity of feline respiratory infections ranges from mild self-limiting conjunctivitis to life-threatening pneumonia, especially in kittens, geriatric cats, and immunocompromised individuals [1]. FHV-1 infection can cause severe ulcerative keratitis, corneal scarring, and symblepharon formation if not managed appropriately [2]. FCV infection may result in oral ulcerations, hypersalivation, and in virulent systemic strains, systemic disease with high mortality [3]. B. bronchiseptica is associated with tracheobronchitis and bronchopneumonia, particularly in young kittens [1]. C. felis typically causes persistent conjunctivitis and mild rhinitis but can lead to chronic ocular disease without treatment [2].

Secondary bacterial infections significantly worsen prognosis and may lead to chronic rhinosinusitis, aspiration pneumonia, and systemic illness [3]. Mortality rates are low in adult cats with adequate immune function but can exceed 30% in kittens with severe viral-bacterial coinfections managed without intensive care [1].

Clinical Signs and Diagnostic Approach

Common clinical signs include serous to mucopurulent ocular and nasal discharge, sneezing, conjunctival hyperemia, chemosis, blepharospasm, oral ulceration, pyrexia, lethargy, anorexia, and in severe cases, dyspnea and open-mouth breathing [2]. Chronic cases may present with nasal congestion, stertor, and persistent ocular discharge [3].

Diagnosis is based on clinical presentation, history, and confirmatory laboratory testing. Conjunctival and nasal swabs are collected for pathogen detection. Polymerase chain reaction (PCR) assays are the gold standard for identifying FHV-1, FCV, C. felis, B. bronchiseptica, and Mycoplasma species due to their high sensitivity and specificity [1]. Serology is of limited utility in acute disease due to widespread seroprevalence and vaccine-induced antibodies [2]. Bacterial culture and antimicrobial susceptibility testing should be performed when secondary bacterial infection is suspected or when initial treatment fails [3].

The following Mermaid diagram outlines a diagnostic workflow for feline respiratory infections.

graph TD
    A[Cat presenting with respiratory signs], > B{Clinical history and physical exam}
    B, > C[Ocular/nasal discharge, sneezing, conjunctivitis, oral ulcers]
    C, > D[Collect conjunctival and nasal swabs]
    D, > E[Perform multiplex PCR for FHV-1, FCV, C. felis, B. bronchiseptica, Mycoplasma spp.]
    E, > F{Positive for primary pathogen?}
    F, >|Yes| G[Treat specific pathogen: antivirals for FHV-1, supportive for FCV, antibiotics for bacteria]
    F, >|No| H{Secondary bacterial infection suspected?}
    H, >|Yes| I[Bacterial culture and antimicrobial susceptibility from nasal swab or bronchoalveolar lavage]
    H, >|No| J[Consider non-infectious causes: allergy, foreign body, neoplasia]
    I, > K[Targeted antibiotic therapy based on sensitivity]
    K, > L[Re-evaluate clinical response in 7–10 days]
    G, > L
    L, > M{Clinical improvement?}
    M, >|Yes| N[Continue treatment and monitor]
    M, >|No| O[Repeat diagnostic testing, consider advanced imaging]
    O, > P[CT or rhinoscopy to evaluate for chronic rhinosinusitis]

Clinical Management

Treatment strategies are directed at the identified etiologic agents and supportive care to maintain hydration and nutritional status. Antiviral therapy for FHV-1 includes famciclovir, a prodrug that inhibits viral DNA polymerase, administered at 40–90 mg/kg orally three times daily [1]. Topical cidofovir or idoxuridine ophthalmic drops are used for herpetic keratitis [2]. No specific antiviral is approved for FCV; management relies on supportive care, including fluid therapy, nutritional support, and analgesia for oral ulcers [3].

Antibiotic therapy is indicated for bacterial pathogens. C. felis responds to tetracyclines; doxycycline at 5 mg/kg orally twice daily for 14 days is the first-line choice [1]. B. bronchiseptica is susceptible to tetracyclines and fluoroquinolones; doxycycline or marbofloxacin are commonly used [2]. Mycoplasma species are inherently resistant to beta-lactams due to the absence of a cell wall; macrolides, tetracyclines, or fluoroquinolones are effective [3]. Secondary bacterial infections may require broad-spectrum antibiotics such as amoxicillin-clavulanate or a combination of a beta-lactam with a fluoroquinolone until culture results guide definitive therapy [1].

Supportive measures include humidification to soothe inflamed airways, nebulization with saline or mucolytics, nutritional supplementation via appetite stimulants or feeding tubes, and oxygen therapy for hypoxemic patients [2]. In chronic cases, surgical intervention such as nasal flushing, turbinectomy, or frontal sinus trephination may be indicated to remove inspissated exudate and necrotic debris [3].

Is Cat Respiratory Infection Contagious to Humans

The zoonotic potential of feline respiratory infections is limited but exists for certain pathogens. B. bronchiseptica is a primary pathogen of dogs, cats, and pigs but can cause respiratory disease in immunocompromised humans, particularly those with underlying pulmonary conditions or congenital immunodeficiency [1]. Human infection typically manifests as a pertussis-like illness with paroxysmal cough, though cases of bronchitis and pneumonia have been reported [2]. Transmission occurs via direct contact with infected cat respiratory secretions or fomites [3].

C. felis is considered a rare zoonotic pathogen. Ocular infections in humans, primarily conjunctivitis, have been documented in individuals handling infected cats without appropriate hygiene [1]. The risk is highest among veterinary personnel and shelter workers [2]. Pasteurella multocida, although a secondary invader in feline respiratory disease, is a well-recognized zoonotic agent transmitted through bites, scratches, or direct mucous membrane contact, causing local wound infections, cellulitis, and rarely, respiratory infection in humans [3].

FHV-1 and FCV are not known to cause disease in humans [1]. Mycoplasma felis has occasionally been implicated in human conjunctivitis or respiratory tract colonization but is not considered a significant zoonotic threat [2]. Standard hygiene practices, including hand washing after handling cats and use of gloves when cleaning ocular/nasal discharges, are effective in preventing zoonotic transmission [3].

Conclusion

Feline respiratory infections are multifactorial diseases involving primary viral and bacterial pathogens acting in concert with secondary invaders. Transmission occurs through direct and indirect contact, with stress and high-density housing amplifying spread. Disease severity ranges from mild to life-threatening, particularly in vulnerable populations. Accurate diagnosis using molecular methods allows targeted therapy, which may include antivirals, antibiotics, and intensive supportive care. Zoonotic risk is low but clinically relevant for B. bronchiseptica, C. felis, and P. multocida, emphasizing the importance of infection control measures in veterinary settings.

References

[1] Greene, C. E. (ed.). Infectious Diseases of the Dog and Cat. 4th ed. Saunders Elsevier. (Standard veterinary reference text.)

[2] Sykes, J. E. Canine and Feline Infectious Diseases. Elsevier. (Standard veterinary reference text.)

[3] Chandler, E. A., Gaskell, C. J., & Gaskell, R. M. Feline Medicine and Therapeutics. 3rd ed. Blackwell Publishing. (Standard veterinary reference text.) *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.